For early stage NSCLC, the historic standard of care is a lobectomy.  But the reality is that with the median age of patients with new lung cancer a little over 70 and many patients quite sick from their lung cancer, COPD, and/or other medical problems, not every patient is a great candidate for surgery.

This week, the US FDA made a public announcement to alert the public that it had received reports of several patient deaths from the technique of radiofrequency ablation (RFA) to lung tumors. This is an investigational technique that I described in a prior post, after several members asked about RFA.